# Judith Marin

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/judith-marin/

## Facts

| Field | Value |
| --- | --- |
| Citations | 238 |
| Field | Chronic Kidney Disease and Diabetes |
| h-index | 7 |
| i10-index | 7 |
| Last Known Institution | University of British Columbia |
| OpenAlex ID | https://openalex.org/A5005885193 |
| ORCID iD | 0000-0001-9317-8809 |
| Works | 24 |

## Researcher papers

- [Advancing Palliative Care in Patients With CKD: From Ideas to Practice](https://scholariq.org/papers/advancing-palliative-care-in-patients-with-ckd-from-ideas-to-practice/)
- [Prescription Patterns in Dialysis Patients: Differences Between Hemodialysis and Peritoneal Dialysis Patients and Opportunities for Deprescription](https://scholariq.org/papers/prescription-patterns-in-dialysis-patients-differences-between-hemodialysis-and/)
- [Development and Validation of Nine Deprescribing Algorithms for Patients on Hemodialysis to Decrease Polypharmacy](https://scholariq.org/papers/development-and-validation-of-nine-deprescribing-algorithms-for-patients-on/)
- [Rituximab induction therapy for de novo ANCA associated vasculitis in pregnancy: a case report](https://scholariq.org/papers/rituximab-induction-therapy-for-de-novo-anca-associated-vasculitis-in-pregnancy/)
- [Is C2 Monitoring or Another Limited Sampling Strategy Superior to C0 Monitoring in Improving Clinical Outcomes in Adult Liver Transplant Recipients?](https://scholariq.org/papers/is-c2-monitoring-or-another-limited-sampling-strategy-superior-to-c0-monitoring/)
- [Chronic Kidney Disease and End Stage Renal Disease](https://scholariq.org/papers/chronic-kidney-disease-and-end-stage-renal-disease/)
- [Skin Staining Following Intravenous Iron Extravasation in a Patient With Chronic Kidney Disease: A Case Report](https://scholariq.org/papers/skin-staining-following-intravenous-iron-extravasation-in-a-patient-with-chronic/)
- [Entry-Level PharmD Degree Programs in Canada: Some Facts and Stakeholder Opinions](https://scholariq.org/papers/entry-level-pharmd-degree-programs-in-canada-some-facts-and-stakeholder-opinions/)
- [Development and Validation of Patient Education Tools for Deprescribing in Patients on Hemodialysis](https://scholariq.org/papers/development-and-validation-of-patient-education-tools-for-deprescribing-in/)
- [Medications for community pharmacists to dose adjust or avoid to enhance prescribing safety in individuals with advanced chronic kidney disease: a scoping review and modified Delphi](https://scholariq.org/papers/medications-for-community-pharmacists-to-dose-adjust-or-avoid-to-enhance/)
- [Canadian Society of Nephrology Commentary on the Evolving Kidney Disease Improving Global Outcomes Adult Glomerulonephritis Guidelines](https://scholariq.org/papers/canadian-society-of-nephrology-commentary-on-the-evolving-kidney-disease/)

## Researcher topics

- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Pharmaceutical Practices and Patient Outcomes](https://scholariq.org/topics/pharmaceutical-practices-and-patient-outcomes/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)

## Researcher university

- [University of British Columbia](https://scholariq.org/institutions/university-of-british-columbia/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
